Investments in 2021 could rival 2020 as investors expect innovation to come from areas such as data interoperability, mental health and personalized...
COVID-19
An interview with Noubar Afeyan, co-founder and chairman of Moderna, about the timeline of the company's remarkable "from outrageous, to obvious, to...
Global venture funding to female-founded companies fell significantly in 2020. Although investors and entrepreneurs say it's not clear if the decline...
Hundreds of startups focused on vaccines, testing kits and other COVID-19 products are riding the big pharma momentum.
Apparently, the U.S. companies that launched the most valuable IPOs of the year--including two this week--didn’t get the memo that Silicon Valley and...
While Airbnb preps for its blockbuster IPO, earlier-stage travel startups are still struggling. With a vaccine and travel pickup on the horizon for...
Global funding slowed down a little in November, year over year, following a blockbuster third quarter. All told, global funding last month came in...
The COVID-19 pandemic and possible vaccine has moved supply chain and logistics technologies into the public eye. However, just as the industry has...
With the right fundraising strategy, marketplace shake-ups can create new opportunities for early-stage businesses in the COVID-era.
The travel and hospitality sectors have been among the hardest hit amid the COVID-19 pandemic, but news of Pfizer, Moderna and AstraZeneca's COVID-19...
A handful of tech companies that have gone public recently have posted huge gains in aftermarket trading, some adding tens of billions to their...
67.1K Followers